← Back to All Filings

UnitedHealth (UNH) Director Awarded Dividend Equivalent Shares

Low SignificanceDecember 18, 2025 at 5:36:44 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UnitedHealth (UNH) Director Awarded Dividend Equivalent Shares

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low

Insider: Baker Charles D. Title: null | Relationship: Director

Transaction: • Type: Grant • Shares: 11 • Price: $0.00 • Value: $0 • Owned After: 1,527

Key Insight: This is a routine, non-cash transaction representing dividend equivalents on existing deferred stock units, having no material impact on the company or the insider's holdings.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director was awarded 11 shares as dividend equivalents on existing deferred stock units, a routine and non-material transaction.
  • Market Impact: Neutral. The transaction is negligible in size and has no market-moving implications.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHOSPITAL & MEDICAL SERVICE PLANS

Insider Information

FieldValue
NameBaker Charles D.
CIK0001554088
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA
Security TypeCommon Stock
Shares Involved11
Price Per Share$0.00
Total Value$0
Shares Owned After1,527
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted11
% of Shares Outstanding<0.00001%
Post-Transaction Ownership1,527 shares (<0.0002% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $291.55 billion, this $0 value transaction is statistically insignificant.
  • Ownership Concentration: The director's total holding of 1,527 shares represents a negligible fraction of the 905.7 million shares outstanding.
  • Dilution Impact: The issuance of 11 shares has no dilutive impact on existing shareholders.
  • Transaction Significance: The transaction is a routine award of dividend equivalents, as noted in the filing's footnotes. It does not represent a new investment decision by the insider and carries no trading signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a non-cash, automated award of dividend equivalents with a total value of $0. It is too small to have any impact on the stock price or market sentiment.

Volume & Sentiment

  • Expected Volume Impact: None. This is a non-market transaction.
  • Sentiment Indicator: Neutral. The filing is procedural and provides no new information to influence investor sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnote clarifies that the shares represent "dividend equivalents paid on vested deferred stock units." This is a common, automated process for insiders holding such units and is not an active purchase.
Topics:#SECFiling#Form4#UNH#UnitedHealth#InsiderTrading#StockMarket#Investing#Dividend

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.